Ireland
--:--IST
Recruiting Not applicable

Exercise Training in Patients With Myeloproliferative Neoplasms

NCT07384039 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2026-02-04
Last updated
2026-08-14

Condition(s) studied

Myeloproliferative Neoplasms (MPN)

Investigational drug(s) / intervention(s)

Exercise Training

Exercise Training: The intervention includes structured and tailored physical training with individual feedback and adjustments to training frequency, intensity, time and content for a total duration of 3 months. Daily activity is monitored using a wearable activity device (Vivoactive 5, Garmin, Olathe, Kansas, USA). An individual training plan includes moderate endurance and strength exercises usually 3 times a week, with the goal of being physically active for at least 150 minutes per week. Participants receive feedback at least every second week via telemonitoring or in person, depending on their distance from the study center. To avoid overexertion, training is monitored by measuring heart rate and providing individual feedback for adjustments if neccesary.

Study summary

The investigators will investigate the response of an individualized exercise training program on quality of life, cardiorespiratory fitness and disease-specific markers in patients with myeloproliferative neoplasms (MPN). To this end, the investigators will randomly assign patients with MPN to a training group and a waiting control group.

The training group will undergo an individually tailored exercise training program for three months, while the control group will maintain their usual lifestyle for three months and then has the opportunity to undergo the three-month intervention program. At the beginning and at the end of the three-month intervention phase, the investigators will evaluate physical performance, daily physical activity, muscular strength, and self-reported outcomes and compare them between the training and the control group, in order to assess potential benefits of the exercise training program.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * age ≥ 18 years * diagnosis of myeloproliferative neoplasia according to WHO/ICC 2022. Exclusion Criteria: * current participation in another intervention study * the presence of any diseases or functional impairments that, in the opinion of the examining physician, exclude participation in a physical training intervention.

Primary outcome measure(s)

  • Change in power output (in watt) at the respiratory compensation point (RCP) — From baseline to the end of the intervention period at 3 months
    During an incremental exercise test on a bicycle ergometer power output and gas exchange will be measured continuously. Afterwards the RCP (also known as second ventilatory threshold) will be assessed based on the inflection point of the slopes of the tidal volume (VE) and the carbon dioxide output (VCO2).

Trial sites (2)

FacilityCityRegionStatus
Hannover Medical School Hanover Lower Saxony Not Yet Recruiting
Hannover Medical School Hanover Lower Saxony Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07384039 on ClinicalTrials.gov ↗ ← All trials in Germany